PMAM
OACC

Picton Mahoney Asset Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Picton Mahoney Asset Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$794K Hold
75,000
– – 0.01% 708
2025
Q4 		$794K Hold
75,000
– – 0.01% 635
2025
Q3 		$789K Hold
75,000
– – 0.01% 550
2025
Q2 		$783K Hold
75,000
– – 0.01% 432
2025
Q1 		$767K Buy
+75,000
New +$753K 0.01% 346

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Picton Mahoney Asset Management's OACC Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 75,000 shares worth $794K. The position accounts for 0.01% of the portfolio, ranked #708.

Picton Mahoney Asset Management first reported a position in OACC in Q1 2025 and has held it in 5 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Picton Mahoney Asset Management held 75,000 shares of Oaktree Acquisition Corp III Life Sciences worth $794K as of Q1 2026.
  • Picton Mahoney Asset Management left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #708 holding.
  • Picton Mahoney Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 5 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.